← All stocks

Pharvaris N.V.

PHVS Net selling

CIK 0001830487 #1865 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$19.69M

$327.73K on a plan · $11.60M straight out of an exercise

Sold at will

$7.77M

2 of 15 sales

Net

−$19.69M

−$7.77M against sales at will

By person

11 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Schikan Johannes Gerardus Christiaan Petrus

Director

—

$7.00M (1)

−$7.00M

115,167

0.1766%

$4.41M

−70.9%

Lu Peng

President

—

$4.71M (3) scheduled

−$4.71M

64,953

0.0996%

$2.49M

−2.0%

Bjork Elisabeth

Director

—

$1.99M (1) scheduled

−$1.99M

15,167

0.0233%

$580.49K

0.0%

Lesage Anne

Chief Early Development

—

$1.91M (2) scheduled

−$1.91M

224,388

0.3441%

$8.59M

−28.6%

Abele Stefan Andreas

Chief Technical Ops Officer

—

$1.77M (2) scheduled

−$1.77M

39,068

0.0599%

$1.50M

−20.6%

Glassman Robert

Director

—

$1.19M (3) scheduled

−$1.19M

10,500

0.0161%

$401.87K

−30.8%

Souverijns Wim

Chief Commercial Officer

—

$1.02M (2) scheduled

−$1.02M

39,021

0.0598%

$1.49M

−29.2%

Modig Berndt

Chief Executive Officer

—

$90.28K (1) scheduled

−$90.28K

778,334

1.19%

$29.79M

−30.2%

Nassif David W.

CFO / CLO

—

120,300

0.1845%

$4.60M

−7.7%

Nijdam Anna

Principal Accounting Officer

—

46,275

0.0710%

$1.77M

−10.7%

Monges Viviane

Director

—

5,500

0.0084%

$210.50K

−63.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 14

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 11

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 608,886

History held since 3 Apr 2026